PerkinElmer

Biotherapeutics Research

OF

Biotherapeutics allow researchers to explore new mechanisms for the treatment of a variety of conditions. Our biotherapeutics research products are designed for consistent and reproducible results, and are a component of GLP-compliant processes in the world's leading pharmaceutical, biotechnology and contract research organizations.

Effective biotherapeutic workflows make use of our portfolio of assays and reagents, multimode plate readers, instrumentation, automation solutions, informatics, and technical expertise.

Our biotherapeutics products include:

  • LANCE® TR-FRET technology for Fc-receptor binding and isotyping
  • AlphaLISA® isotyping, Fc-receptor binding, and bioprocess contaminant detection kits
  • DELFIA® (dissociation-enhanced lanthanide fluorescence immunoassay) TRF technology
  • Multimode plate readers
  • Cellular, tissue, and in vivo imaging systems

Accelerate the development and marketability of your biotherapeutic drugs while still meeting stringent regulatory demands. With our technology and guidance, numerous biotherapeutic drugs have been approved for the treatment of cancer, inflammatory disease, and several rare diseases.

For Research Use Only. Not for diagnostic procedures.

Target Identification
Target Identification

Target Identification

Identify relevant disease targets during the early stages of discovery for new biotherapeutics. Avoid latent failures downstream by thorough validation of each target. We provide the capability for the most accurate prediction of target relevance in human disease through a combination of in in vitro and in vivo approaches.
  • Cellular imaging for in vitro target validation
  • In vivo imaging for target discovery
  • Tissue imaging for ex vivo target validation
Protein Antibody
Protein Antibody

Cloning and Expression

We offer a range of microfluidic, ELISA-alternative, imaging, informatics, detection and automation solutions that simplify workflow and improve the quality of data generated at every stage in the cloning and expression process:
  • Clone Selection
  • Protein Purification
  • Functional Screening
  • Bioanalytical Characterization
General laboratory
General laboratory

Safety and Preclinical

Accurately quantify anti-drug antibodies (ADA) and pharmacokinetics (PK) / pharmacodynamics (PD) through high quality, reproducible test data. Whether your research involves monoclonal antibodies (mAb) or proteins and peptides, our wide portfolio of immunogenicity, neutralizing antibody (NAb) and PD/PK testing solutions can streamline your workflow.
Pipetting
Pipetting

Manufacturing and QC

Identify process and product related impurities to ensure they do not compromise the quality or safety of your biotherapeutics or vaccine research.

LabChip® microfluidic technology provides rapid and reproducible purity analysis for therapeutic proteins and detection and visualization of low concentration impurity peaks down to 5 ng/µL accelerating manufacturing and QC processes.

Products & Services (188)
Filters:

Filters :

Product Type
  • Accessories (37)
  • Consumables (11)
  • Instruments (18)
  • Reagents (113)
  • Software and Informatics (9)
Assay Target
  • 4EBP1 (1)
  • Albumin (2)
  • C-peptide (1)
  • CHO HCP (1)
  • CHO-P (2)
  • E.coli HCP (2)
  • EGFR (1)
  • FCGR1 (1)
  • FCGR2A (2)
  • FCGR2B (1)
  • FCGR3A (8)
  • GSK3β (1)
  • IgA (3)
  • IgE (3)
  • IgG (8)
  • IgG1 (4)
  • IgG2 (2)
  • IgG2a (1)
  • IgG2b (1)
  • IgG3 (1)
  • IgG4 (2)
  • IgM (6)
  • INSR (1)
  • JNK1/2/3 (1)
  • Kappa light chain (4)
  • Lambda light chain (4)
  • MEK1 (2)
  • mTOR (1)
  • PER.C6 HCP (3)
  • Protein A (1)
  • Residual DNA (4)
  • Residual Protein A (1)
  • S6RP (1)
  • SLP-76 (1)
  • STAT3 (1)
  • STAT4 (1)
  • STAT5 (2)
  • VEGF2 Receptor (1)
Target Species
  • Bovine (8)
  • CHO (1)
  • Human (49)
  • Mouse (9)
  • Rabbit (2)
Application
  • Antibody binding (2)
  • DNA/RNA Quantitation (1)
  • DNA/RNA Quantitation and QC (3)
  • Isotyping (11)
  • Kinase (8)
  • Protein Analysis (9)
  • Protein Analysis & Detection (94)
  • Protein-protein interactions (9)
Therapeutic Area
  • Biologics/Bioprocess (66)
  • Inflammation (2)
Product Brand Name
  • Alpha (2)
  • AlphaLISA (61)
  • AlphaLISA SureFire Ultra (15)
  • DELFIA (1)
  • DropletQuant / LabChip DS (1)
  • EnSight (1)
  • EnSpire (2)
  • EnVision (2)
  • FMT (3)
  • G-Platform (1)
  • IVIS (6)
  • JANUS (2)
  • LabChip GX (2)
  • LabChip GXII (13)
  • LANCE Ultra (26)
  • Opera Phenix (1)
  • Operetta (29)
  • Operetta CLS (1)
  • Operetta CLS AND Opera Phenix (7)
  • Victor (1)
Detection Method
  • Absorbance (3)
  • Alpha (80)
  • DELFIA TRF (1)
  • Fluorescence (5)
  • Fluorescence Polarization (2)
  • Image-based Cytometry (1)
  • Luminescence (3)
  • Time-Resolved Fluorescence (TRF) (29)
  • TR-FRET (25)
  • Transmission (2)
Sample Type
  • DNA / RNA (2)
  • Protein (12)
Antibody Conjugates
  • Anti-bovine IgG (1)
  • Anti-bovine IgG1 (1)
  • Anti-bovine IgG2 (1)
  • Anti-bovine IgM (1)
  • Anti-human IgE (1)
  • Anti-human IgG (1)
  • Anti-human IgG1 (1)
  • Anti-human IgG2 (1)
  • Anti-human IgG3 (1)
  • Anti-human IgG4 (1)
  • Anti-mouse IgA (1)
  • Anti-mouse IgE (1)
  • Anti-mouse IgG1 (1)
  • Anti-mouse IgG2a (1)
  • Anti-mouse IgG2b (1)
  • Anti-mouse IgG3 (1)
  • Anti-mouse IgM (1)
  • Human Fc-fragment (1)
Assay Points (200-50,000)
  • 100 (20)
  • 10000 (25)
  • 500 (50)
  • 5000 (25)
  • 50000 (11)
Assay Target Class
  • Antibody (39)
  • DNA (4)
  • Fc-receptor (12)
  • Peptide (1)
  • Phosphoprotein (8)
  • Protein (15)
Automation Compatible
  • Yes (106)
Depth
  • 33.0 in (2)
  • 49.0 cm (1)
Experimental Type
  • In vitro (89)
Format
  • Microplates (93)
Imaging Modality
  • High Content (2)
  • microCT Imaging (1)
  • Optical Imaging (9)
  • PET Imaging (1)
Length
  • 51-100 (1)
  • 101-200 (1)
Maximum Temperature (Celsius)
  • 40-50 (2)
  • 50-60 (2)
Model Compatible With
  • LabChip GXII Touch 24 (1)
  • LabChip GXII Touch HT (1)
  • Operetta (30)
  • Operetta CLS AND Opera Phenix (8)

1-12 of 188 Products & Services

Sort by

  • FMT In Vivo Imaging Instrument

    FMT 1000 In Vivo Imaging System

    The FMT® 1000 is an entry level 3D fluorescence tomographic system with the ability to quantitate a single fluorophore at a time.
  • IVIS Lumina HT High Throughput Benchtop 2D Optical Imaging System

    IVIS Lumina LT In Vivo Imaging System

    The IVIS® Lumina LT Series III pre-clinical in vivo imaging system offers the industries most sensitive benchtop platform at an entry level price.
  • LabChip GX GXII Touch Product

    LabChip GXII Touch Protein Characterization System

    The LabChip® GXII Touch protein characterization system provides the complete solution for reproducible quantitation, molecular weight sizing and percent purity analysis of protein samples. Leveraging microfluidic electrophoretic separation technology, the LabChip® GXII Touch system enables rapid characterization with minimal sample preparation setup and sample input volume.
  • JANUS G3 BioTx Pro Workstation

    JANUS G3 BioTX Pro Workstation

    The affordable and compact JANUS® G3 BioTx Pro Automated Workstation enables consistent, time-saving small-scale protein purification and sample preparation for analytical protein characterization required to support quality by design experimentation in both upstream and downstream processes.

    Ideal Workstation for:

    • Expression optimization
    • Cell line selection
    • Purification process development
    • Bioanalytical sample preparation
  • EnVision 2105 multimode plate reader

    EnVision 2105 Multimode Plate Reader

    The EnVision® 2105 multimode plate reader provides exceptional speed, ultra-high throughput, and maximum sensitivity across all detection technologies. Tried and tested, the EnVision microplate reader gives you robust performance and reliable data for high throughput screening, time after time.

    The EnVision 2105 model delivers even higher sensitivity for time-resolved fluorescence (TRF) applications, and the Enhanced Security software option includes tools to facilitate 21 CFR Part 11 compliance for integration into regulated environments (GxP). In addition, the Alpha 775 laser module is designed for plant assays.

  • IVIS Spectrum In Vivo Imaging System

    IVIS Spectrum In Vivo Imaging System

    The IVIS® Spectrum in vivo imaging system combines 2D optical and 3D optical tomography in one platform. The system uses leading optical technology for preclinical imaging research and development ideal for non-invasive longitudinal monitoring of disease progression, cell trafficking and gene expression patterns in living animals.
  • IVIS Lumina XRMS 2D Optical Imaging System with Integrated X-ray

    IVIS Lumina XRMS In Vivo Imaging System

    Industry leading Fluorescence, Bioluminescence and X-Ray Imaging - All-In-One benchtop instrument! The IVIS® Lumina XRMS (x-ray multi-species optical imaging system) adds to the versatility of the IVIS Lumina XR by offering the flexibility to image large animals up to 500 grams with precise optical and X-Ray overlay.
  • FMT In Vivo Imaging Instrument

    FMT 2000 In Vivo Imaging System

    The FMT 2000 is a workhorse 3D fluorescence tomographic system with the ability to quantitate up to two fluorophores simultaneously.
  • JANUS G3 Btx Pro-Plus

    JANUS G3 BioTx Pro Plus Workstation

    The JANUS® G3 Bio Tx Pro Plus offers full walk-away automation for high-throughput process development, enabling more data from precious starting materials and limited resources.
  • 1000x1000_Operetta

    Operetta CLS High-Content Analysis System

    Uncover deep biological understanding in your everyday assays and innovative applications using the Operetta CLS high-content analysis system. Featuring a unique combination of technologies, the system delivers all the speed, sensitivity and resolution you need to reveal fine sub-cellular details. And with our simple, powerful Harmony 4.5 software, Operetta CLS lets you find even subtle phenotypic changes.
  • IVIS SpectrumCT 2D/3D Optical/CT In Vivo Imaging System

    IVIS SpectrumCT In Vivo Imaging System

    The IVIS® SpectumCT preclinical in vivo imaging system expands upon the versatility of the IVIS Spectrum by offering 2D and 3D imaging capabilities but includes integrated low-dose microCT ideal for longitudinal studies. The system provides researchers with greater insights into complex biological systems by enabling simultaneous molecular and anatomical non-invasive imaging in animal models.
  • IVIS Lumina HT High Throughput Benchtop 2D Optical Imaging System

    IVIS Lumina III In Vivo Imaging System

    The IVIS® Lumina Series III brings together years of leading optical imaging technologies into one easy to use and exquisitely sensitive bench-top system.
  • Jump to:
Business Insights (17)
Filters:

Filters :

Resource Library
  • Application Note (12)
  • Case Study (1)
  • Poster (3)
  • White Paper (1)

1-12 of 17 Business Insights

Sort by

  • White Paper

    Streamlining Materials Innovation Processes with Electronic Lab Notebook (ELN) and Data Analytics for Optimum Efficiency

    This paper explores the numerous challenges materials scientists and engineers face, from the time it takes to bring new materials to market to the difficulties delivering suitable formulations and testing against specified criteria, and how those can be resolved.

  • Application Note

    Preclinical Fluorescence Imaging of Cancer Metastasis to the Lung and Response to Therapy

    Quantitative pre-clinical fluorescence imaging transcends the boundaries of traditional optical imaging of biological structures and physiology by providing information at the molecular level about disease states and therapeutic response. Fluorescent Pre-clinical Imaging Agents and FMT® (Fluorescence Molecular Tomography) Quantitative Pre-clinical Imaging Systems represent powerful tools for research and drug development in the imaging of biological processes and pharmaceutical activity in living animals.

  • Application Note

    Stem Cell Research and Regenerative Medicine

    With the potential to treat a wide range of disease, from organ damage to congenital defects, stem cell research and tissue engineering form the underlying basis of regenerative medicine. Significant advances in the science of skin regeneration, for example, have now made it possible to develop and grow artificial skin grafts in a lab for treatment of burn victims. Other therapeutic applications include the use of stem cells to treat and repair central nervous system diseases such as ischemia and cerebral palsy, cardiovascular diseases, as well as autoimmune diseases including type I diabetes.

  • Application Note

    Imaging Hepatocellular Liver Injury using NIR-labeled Annexin V

    Drug induced liver injury (DILI) is a major reason for late stage termination of drug discovery research projects, highlighting the importance of early integration of liver safety assessment in the drug development process. A technical approach for in vivo toxicology determination was developed using Acetaminophen (APAP), a commonly used over-the-counter analgesic and antipyretic drug, to induce acute hepatocellular liver injury.

  • Application Note

    NIR Fluorescent Cell Labeling for In Vivo Cell Tracking (VivoTrack 680)

    Fluorescent dyes have been used for many years to label cells for microscopy studies, and a variety of dyes in the visible fluorescence spectrum are available to label different cellular compartments and organelles. Efficient delivery of the fluorophore to the cell without excessively modifying surface proteins or perturbing cell function is the major biotechnological challenge. In addition, researchers have taken on the challenge of in vivo imaging, focusing on near infrared (NIR) dyes that fluoresce in a spectral region better suited for in vivo imaging due to reduced background and higher tissue penetration.

  • Application Note

    Analyzing ERK Signal Transduction in Live Cells Using a FRET-Based Biosensor

    Extracellular signal-regulated kinase (ERK) is a key component in the regulation of embryogenesis, cell differentiation, cell proliferation, and cell death. The ERK signaling pathway is altered in various cancer types and is frequently investigated as a target for therapeutic intervention. This application note describes how a live cell FRET assay to study ERK signaling was performed on the Operetta CLS™ high-content analysis system. The optimized design of the FRET-based biosensor, the high-quality imaging of the Operetta CLS system and the easy-to-use image analysis tools of the Harmony® software contribute to the robustness of the high-content assay.

  • Application Note

    Imaging Bile Canaliculi in 3D Liver Microtissues using the Opera Phenix HCS System

    Analyzing transport of biliary metabolites is essential to predict pharmacokinetics and hepatotoxicity during drug development. A functional impairment of hepatobilary transporters, such as bile salt export pump (BSEP) and multidrug resistance-associated protein 2 (MRP-2), is strongly associated with an increased risk of cholestatic liver injury. Here, we describe a 3D high-content screening assay to study hepatobiliary transporter function in InSphero human liver microtissues. Confocal imaging and automated image analysis were used to quantify BSEP and MRP-2-mediated efflux of fluorescent substrates into bile canaliculi.

  • Application Note

    Phenotypic Analysis of Hypertrophy in Human iPSC-Derived Cardiomyocytes

    Learn how a phenotypic screening assay to study time-dependent effects of endothelin-1-induced hypertrophy was set up using human induced pluripotent stem cell (hiPSC)-derived cardiomyocytes. Learn how: The Opera Phenix system has been applied in the field of neurodegenerative diseases. In this assay, the Opera Phenix system is 4 times faster than the previous Opera® system. Primary neuron morphology is analyzed in a straightforward approach using Harmony software. Careful assay optimization can increase throughput, and minimize the data burden, without compromising assay performance.

  • Application Note

    Measuring FRET using the Opera Phenix High-Content Screening System

    Fundamental processes in living cells, such as apoptosis and signal transduction are controlled by proteins, often acting in concert with other protein partners through protein-protein interactions (PPIs). Inappropriate protein-protein recognition can fundamentally contribute to many diseases, including cancer. Therefore, inhibiting protein-protein interactions represents an emerging area in drug design.

  • Application Note

    Distinguishing Cell Types by Phenotypic Profiling of the Nucleus

    The promise of high-content screening is the acceleration of discovery by extracting as much relevant information as possible from cells. Nevertheless, a large percentage of high-content screens analyze only a small number of image-based properties. As a result, valuable information from precious cells and disease models is not utilized. As nearly all screening approaches require a nuclear counterstain such as Hoechst to facilitate segmentation, phenotypic profiling of the nuclei can offer new and additional perspectives on assays at no extra cost.

  • Application Note

    Phenotypic Profiling of Autophagy using the Opera Phenix High-Content Screening System

    Cells constantly sense their environment and their response is a spatio-temporal summation of all signals. To maintain physiological stability, cells need to adjust to environmental changes, a process called homeostasis. One of the most important processes involved in maintaining homeostasis is autophagy, and its significance was recognized by the award of the Nobel Prize for Physiology in 2016 to Yoshinori Ohsumi for the discovery of its underlying mechanisms. Although this is not fully understood, it is believed that autophagy can prevent tumor development by degrading, for example, damaged organelles and protein aggregates.

  • Application Note

    Vascular Imaging Probes For Oncology and Inflammation Using the IVIS Spectrum

    Optical-based in vivo imaging of vascular changes and vascular leak is an emerging modality for studying altered physiology in a variety of different cancers and inflammatory states. A number of fluorescent imaging probes that circulate with the blood, but have no target selectivity, have been used to detect tumor leakiness as an indication of abnormal tumor vasculature. Inflammation is also characterized by distinct vascular changes, including vasodilation and increased vascular permeability, which are induced by the actions of various inflammatory mediators. This process is essential for facilitating access for appropriate cells, cytokines, and other factors to tissue sites in need of healing or protection from infection. This application note investigates the use of three fluorescent imaging probes, to detect and monitor vascular leak and inflammation in preclinical mouse breast cancer models.

  • Jump to: